128 results on '"Al-Hashel, J."'
Search Results
2. Neurologic complications after bariatric surgery: EP4262
3. Postoperative supplementary motor area syndrome: clinical evolution and prognosis in nine patients after left hemispheric tumor resection
4. Treatment satisfaction with botulinum toxin in different neurological disorders: A clinic-based study
5. Prevalence and burden of primary headache disorders among primary and middle school students in Kuwait
6. Levodopa/carbidopa intestinal gel in treatment of non-motor symptoms in advanced Parkinson's disease
7. Radiological characteristics of neuromyelitis optica spectrum disorder in Kuwait: A tertiary neurology centre experience
8. Bumetanide to treat Parkinson's disease patients suffering from freezing of gait resistant to both dopamine replacement treatment and STN DBS: An open-label pilot study (BUMFOG)
9. Botulinum toxin in migraine: Rationale and patient selection
10. Reduction of multiple sclerosis burden with specialised multiple sclerosis clinic
11. Risk of Relapses During Pregnancy and Post-partum Period Among Multiple Sclerosis Patients
12. A Longitudinal Study of JC Virus Serostatus Stability Among Multiple Sclerosis Patients
13. Prevalence and burden of migraine in kuwaiti population: A door-to-door survey
14. The use of Alemtuzumab in multiple sclerosis patients in a clinical setting, Kuwait experience
15. Prevalence of myasthenia gravis in kuwait. A tertiary neurological centre study
16. Consensus recommendations for the diagnosis and treatment of multiple sclerosis in Kuwait
17. Association of cognitive abilities and handedness among primary school children in Kuwait
18. The value of D-dimer test for diagnosis of cerebral venous thrombosis in Kuwait neurological center
19. Rate of sero-conversion of anti-JC virus antibody among multiple sclerosis patients in Kuwait
20. Puberty does not affect clinical presentation of multiple sclerosis in children
21. Incidence and prevalence of pediatric onset multiple sclerosis in Kuwait: 1994–2013
22. Clinical predictors of disease progression in multiple sclerosis patients with relapsing onset in a nation-wide cohort
23. Real world use of fingolimod in patients with relapsing remitting multiple sclerosis: A retrospective study utilising the national multiple sclerosis registry in Kuwait
24. The risk of short-term relapse in patients switching from natalizumab to fingolimod
25. Demographics and clinical characteristics of pediatric onset multiple sclerosis
26. Clinical predictors of disease progression in multiple sclerosis patients with relapsing onset in a Nation-Wide Cohort
27. Pediatric onset multiple sclerosis patients tend to have slower disease progression
28. Use of fingolimod in patients with relapsing remitting multiple sclerosis in Kuwait
29. Demographics and Clinical Characteristics of Multiple Sclerosis in Kuwait
30. Efficacy of fingolimod treatment in relapsing multiple sclerosis patients in clinical practice: A multicenter experience
31. Increasing prevalence and incidence rates of multiple sclerosis in Kuwait
32. Use of Natalizumab in Patients with Active Relapsing-Remitting Multiple Sclerosis in Kuwait
33. Clinical predictors of disease progression in multiple sclerosis patients with relapsing onset in a nation-wide cohort.
34. Predictors of Conversion to Multiple Sclerosis in Patients with Clinical Isolated Syndrome Using the 2010 Revised McDonald Criteria
35. P026 - Real world use of fingolimod in patients with relapsing remitting multiple sclerosis: A retrospective study utilising the national multiple sclerosis registry in Kuwait
36. P028 - The risk of short-term relapse in patients switching from natalizumab to fingolimod
37. P012 - Pediatric onset multiple sclerosis patients tend to have slower disease progression
38. P003 - Demographics and clinical characteristics of pediatric onset multiple sclerosis
39. P002 - Clinical predictors of disease progression in multiple sclerosis patients with relapsing onset in a Nation-Wide Cohort
40. Increasing prevalence and incidence rates of multiple sclerosis in Kuwait.
41. Cutaneous silent period in the assessment of small nerve fibers in patients on hemodialysis
42. Substantial and comparable suppression of disease activity following early initiation of cladribine tablets, ocrelizumab or alemtuzumab as first pharmacologic treatment for relapsing multiple sclerosis: A real world study.
43. Unmet Needs of Patients Living with Migraine in the Gulf Cooperation Council (GCC) Countries.
44. Population Pharmacokinetics of Topiramate in Patients with Epilepsy Using Nonparametric Modeling.
45. Real world study of ocrelizumab in multiple sclerosis: Kuwait experience.
46. A prospective observational longitudinal study with a two-year follow-up of multiple sclerosis patients on Cladribine.
47. Commentary: Consensus Guidelines on the Appropriate Use of Brand-Name and Generic Anti-Seizure Medication for the Management of Epilepsy in the Gulf Region.
48. A real-life study of alemtuzumab in persons with multiple sclerosis: Kuwait's experience.
49. Reply to: Instagram for Measuring Tremor: Who Holds the Camera?
50. COVID-19 vaccination in people with multiple sclerosis, real-life experience.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.